Pamir Ozan
- SEC CIK
- 0001834681
In the past year, 1 open-market purchase filing worth $45.6K and no sales.
Current role at each company
- NAGE Niagen Bioscience, Inc.Chief Financial Officeras of Jul 8, 2026
- FRMM Forum Markets IncCFOas of Sep 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $45.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$45.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pamir Ozan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NAGE Niagen Bioscience, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Pamir OzanChief Financial Officer | PPurchase | +4.46K | $6.81 | +$30.4K | +153.6%7.37K after | |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Pamir OzanChief Financial Officer | PPurchase | +2.22K | $6.85 | +$15.2K | New position2.22K after | |
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Pamir OzanChief Financial Officer | PPurchase | +2.91K | $7.36 | +$21.4K | New position2.91K after |
FRMM Forum Markets Inc
CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 (view filing) | May 18 | 1 day | Pamir OzanCFO | PPurchase | +5.16K | $1.01 | +$5.21K | +135.1%8.98K after | |
| Dec 13, 2021 (view filing) | Dec 10 | 3 days | Pamir OzanInterim CFO | PPurchase | +3.80K | $3.87 | +$14.7K | +5.2%76.4K after |